Pazopanib for Treating Uterine Leiomyosarcoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2015

Primary Completion Date

January 31, 2018

Conditions
Uterine Leiomyosarcoma
Interventions
DRUG

Pazopanib

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Gynecologic Oncology Group

NETWORK